Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center, Prospective, Open-Label, Exploratory, Single-Arm Real-World Study of Upadacitinib in Patients With Moderate-to-Severe Hidradenitis Suppurativa

NCT07727889 is registered in ClinicalTrials.gov with Peking Union Medical College as lead sponsor.

NCT NCT07727889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07727889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center, Prospective, Open-Label, Exploratory, Single-Arm Real-World Study of Upadacitinib in Patients With Moderate-to-Severe Hidradenitis Suppurativa
Lead sponsor
Peking Union Medical College
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 1, 2026
Completion date
July 1, 2027
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa (acne inversa)